A new CVM study will determine the effectiveness of a novel method of sustained ocular release of celecoxib, an anti-inflammatory medication that can
decrease ocular inflammation and eliminate «after - cataract».
For reasons that are poorly understood, some dogs have no apparent orbital
inflammation while others have severe orbital swelling, pain,
decreased ocular retropulsion and exophthalmos.